Press Release

PLYMOUTH, Michigan – Nov. 28, 2016. Materialise NV (Nasdaq: MTLS), a world leading 3D printing solutions provider, has launched AnatomyPrint, an easy-to-use service for medical professionals that delivers 3D printed anatomical models directly to their doorsteps. The new service was launched during the 2016 RSNA Scientific Assembly and Annual Meeting at McCormick Place in Chicago.

Materialise offers a full suite of medical 3D printing solutions, including medical 3D printing software, high-end anatomical model for surgical preparation and planning, and printing services including segmentation and design services. AnatomyPrint now completes this set of tools for the medical industry, providing a simple and fast way to obtain 3D printed models.

AnatomyPrint users simply upload an STL file and choose their preferred material, and Materialise will deliver a high-quality, 3D printed anatomical model. These Class 1 medical devices can be used for visualization, for communication with patients and other physicians as well as educational purposes. This service improves access to 3D printed anatomical models by allowing radiologists, clinicians and other medical professionals to quickly and easily obtain models without the cost of purchasing their own 3D printer.

"High quality 3D printed anatomical models serve as a valuable visualization and education aid for medical professionals working with peers as well as with patients," said Materialise Founder and CEO Wilfried Vancraen. "AnatomyPrint offers a fast and easy way to order and print models from STL files that can be generated from the DICOM images that medical professionals work with on a daily basis. This is an important service for medical professionals working in organizations without in-house 3D printing capabilities, as it allows them to access these models and stay up to date with the latest industry technology without making a major investment."

Materialise has leveraged more than 26 years of experience in the 3D printing industry to develop software and services that act as the backbone of 3D printing in the medical field, helping partners efficiently develop and implement solutions for their customers and improving access to the cost-savings and customization benefits of 3D printing.

Carestream, a worldwide provider of dental and medical imaging systems and IT solutions, also announced that it will collaborate with Materialise during the 2016 RSNA annual meeting, leveraging the new AnatomyPrint service to improve access to 3D printed anatomical models for its customers in the medical industry.

AnatomyPrint can be seen on display during RSNA at the Materialise exhibit, located at booth #7808 in North Hall B and at the Carestream exhibit, located at booth #4704 in South Hall A.

About Materialise

Materialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of 3D printing technologies. Materialise's open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Press contacts:

Virginia Goble
 Phone: 734.259.6445
 Mobile : 248.921.5500
 Email: virginia.goble@materialise.com
 Twitter: @MaterialiseNV
 Visit: www.materialise.com

Ann Marie Fortunate Franco
 Phone: 313.567.5040
 Mobile: 586.214.1731
 Email: fortunate@franco.com

Cautionary Statement on Forward-Looking Statements Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements relating to, among other things, our planned commercialization efforts and regulatory approvals of our technologies as well as the success thereof and our research and development projects. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control that may cause our actual results to differ materially from our expectations. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this presentation as a result of new information, future events or otherwise, unless we have obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.